Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update

21 Dec 2011 07:00

RNS Number : 3629U
Greenwich Loan Income Fund Ltd
21 December 2011
 



 

Greenwich Loan Income Fund Limited

Pre-close Trading Update

21 December 2011

Greenwich Loan Income Fund Limited ("GLIF" or "the Company") today announces an update prior to its year end of 31 December 2011.

T2 CLO I Ltd

The majority of GLIF's loan exposure is currently through T2 CLO I Ltd ("the CLO"). It was announced on 27 April 2011 that the Company was to undertake a strategic review of its holding of the CLO, with a view to potentially selling part or all of its exposure. Whilst a number of proposals were received, none reflected the far lower risk profile of the CLO than the CLO market as a whole. Thus to have sold and reinvested would have increased the Company's risk profile without a commensurate increase in return. Given the Board's firm commitment to maintain the risk/reward profile of the business in any transaction, it was decided to maintain the current holding in the CLO.

The fact that the CLO is significantly lower risk than the CLO market in general is reflected in the fact that all of the tranches of loan notes within the CLO structure are now rated at either the same or above the rating when they were first issued by Moody's and S & P.

The assets within the CLO continue to perform well and strong coverage of the overcollateralization tests has been maintained, whilst the spread achieved on the portfolio has been increased. Given the decision to maintain the CLO holding, the two equity positions within the CLO, CBA Group and Provo Craft will be valued by an independent valuation firm and shown in the consolidated accounts. Previously no value had been attributed to these holdings.

Although there are many uncertainties surrounding the global economy in 2012, it should be noted that the CLO continued to pay interest to GLIF throughout the 2008/9 period, reflecting its lower leverage than most other CLOs, so the Company remains well positioned going forward.

Management fee reduction and review of dividend

The management fee reduction announced earlier in the year will affect the cash flow of GLIF for the first time at the end of the first quarter of 2012. This reduction will have a material positive impact on the net income and cash flow of GLIF and the Board will review the level of the dividend at that time. However, given that the dividend is payable in sterling, whilst the vast majority of the Company's returns are in dollars and the commitment of the Company to a progressive dividend policy, it is likely that any increase in the dividend will be less than the increase in the Company's net income. The Board of GLIF believes that the dependable sterling dividend stream is more valuable in the long run to sterling based investors than an uncertain level.

Acquisition of Asset Management Investment Company plc ("AMIC")

The Company acquired AMIC at the end of January 2011, for £9.1m in debt and £3.2m in equity. Since that date the debt has been repaid, and at the year-end the Company expects to have booked a profit of approximately £1.7m on the investments whilst the revenue stream from the remaining investments is expected to be approximately £0.8m annually.

The Company retains exposure to two businesses from the AMIC portfolio. Lombardia Capital Partners, where GLIF owns a warrant over 2.65% of the equity and a $2.5m loan, and IFDC where AMIC retains a 17.23% stake.

Lombardia has indicated to GLIF that it intends to prepay approximately 15% of the loan agreed in June, to replace the previous convertible held by AMIC, reflecting the strong results of Lombardia. The holding of IFDC will be valued at year-end with reference to the net asset value, resulting in an uplift of approximately £1.3m. Both the Lombardia loan and IFDC equity provide ongoing income.

Other CLO Equity

The Company's manager has extensive experience in managing portfolios of CLO equity through its two US-listed vehicles, TICC and Oxford Lane Capital. GLIF has taken advantage of both the managers' knowledge and experience in the CLO market to purchase two other positions in the CLO equity market. These positions increase the diversity and quantum of the GLIF revenue. The first interest payments are expected to exceed $500,000 in aggregate and are payable early in the first quarter of 2012.

Outlook

Uncertainty within the wider global economy will continue to shape the investment horizon in the CLO market over the next 12 months. However, the scale and variety of instruments in the CLO market (US-$250bn, Europe-$70bn) and the shifting pricing dynamics, continually provide opportunities for the Company to accrete value for its shareholders.

Additionally the Company continues to explore other opportunities in the loan market, outside of CLO structures. The Manager already has significant experience in both the syndicated and bilateral loan markets in the US, and the global shortage of capital suggests that there may be opportunities to enhance the Company's long-term prospects for dividend and capital growth from this area.

Furthermore, the success of the AMIC acquisition supports the Board's decision to consider further accretive acquisitions of other managers, if they are complementary to the existing business and long term investment strategy.

 

For further information, please contact:

Contacts:

Geoffrey Miller

Greenwich Loan Income Fund Limited

+353 1 4433 466

 

Patrick Conroy

Greenwich Loan Income Fund Limited

+1 203 983 5282

 

Philip Secrett

Nominated Adviser

Grant Thornton Corporate Finance

+44 207 383 5100

 

James Maxwell

Singer Capital Markets Limited

+44 20 3205 7623

 

Ed Berry

Financial Dynamics

+44 (0) 207 269 7297

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLRFRLIFIL
Date   Source Headline
10th Jul 20187:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Jul 20187:00 amRNSSale of loan assets
20th Jun 20183:14 pmRNSHolding(s) in Company
11th May 20181:51 pmRNSResult of AGM
19th Apr 20189:11 amRNSHolding(s) in Company
13th Apr 201812:30 pmRNSAnnual Report and Accounts & Notice of AGM
10th Apr 20183:44 pmRNSUpdate on FinTech platform
28th Mar 20185:31 pmRNSDirector/PDMR Shareholding
26th Mar 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
28th Feb 20189:14 amRNSFirst draw-down of the HIT funding-facility
29th Jan 201811:05 amRNSSecond Price Monitoring Extn
29th Jan 201811:00 amRNSPrice Monitoring Extension
29th Jan 20187:02 amRNSRepayment of Sancus Loan Note 1
29th Jan 20187:00 amRNSNew Funding Facility
12th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 201812:03 pmRNSHolding(s) in Company
21st Dec 201712:43 pmRNSDirector/PDMR Shareholding
24th Nov 20177:00 amRNSFurther investment in Sancus Isle of Man
23rd Nov 20174:30 pmRNSChange of Registered Office
26th Sep 20174:30 pmRNSGrant of Options
25th Sep 20173:38 pmRNSLaunch of third securitised loan note SPV
25th Sep 20177:00 amRNSInterim Results
10th Aug 20179:05 amRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
14th Jul 20171:00 pmRNSFundingKnight granted full FCA authorisation
10th Jul 20175:11 pmRNSDirector/PDMR Shareholding
3rd Jul 20178:53 amRNSIncrease in stake in Sancus Finance Limited
25th May 201710:15 amRNSDirector/PDMR Shareholding
12th May 20172:31 pmRNSChange in Senior Management Team
10th May 20174:49 pmRNSResult of Annual General Meeting
2nd May 20177:00 amRNSInvestment in second securitised loan note SPV
27th Apr 20174:44 pmRNSDirector/PDMR Shareholding
20th Apr 20177:00 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
13th Apr 20179:02 amRNSAnnual Report & Accounts & Notice of AGM
27th Mar 201711:59 amRNSAnnual Report & Accounts, year ended 31.12.16
27th Mar 20177:02 amRNSConsolidatedFinancial Statements year end 31.12.16
27th Mar 20177:02 amRNSFurther investment in Sancus Isle of Man
13th Mar 20177:00 amRNSTrading Update
10th Mar 20172:30 pmRNSHolding(s) in Company
8th Mar 20179:05 amRNSSecond Price Monitoring Extn
8th Mar 20179:00 amRNSPrice Monitoring Extension
8th Mar 20177:00 amRNSProposals Re. The SME Loan Fund plc - Update
24th Feb 20174:35 pmRNSPrice Monitoring Extension
22nd Feb 20178:59 amRNS2016 Fourth Interim Dividend
21st Feb 20177:03 amRNSProposals Re. The SME Loan Fund plc
6th Feb 201710:15 amRNSFurther investment in Sancus Isle of Man
19th Jan 20173:03 pmRNSDirector / PDMR Shareholding - Replacement
19th Jan 201712:44 pmRNSDirector/PDMR Shareholding
11th Jan 20175:01 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Jan 20171:19 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Jan 20171:18 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.